======= NMT1 ======= == Gene Information == * **Official Symbol**: NMT1 * **Official Name**: N-myristoyltransferase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4836|4836]] * **UniProt**: [[https://www.uniprot.org/uniprot/P30419|P30419]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NMT1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NMT1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/160993|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Adds a myristoyl group to the N-terminal glycine residue of certain cellular and viral proteins. {ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:9353336, ECO:0000269|PubMed:9506952}. |NMT| |NMT C| |myristoyltransferase activity| |glycylpeptide N-tetradecanoyltransferase activity| |N-terminal peptidyl-glycine N-myristoylation| |peptidyl-glycine modification| |protein myristoylation| |N-terminal protein myristoylation| |N-terminal protein lipidation| |regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway| |regulation of rhodopsin mediated signaling pathway| |positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway| |N-terminal protein amino acid modification| |positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway| |regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway| |positive regulation of establishment of protein localization to mitochondrion| |extrinsic component of membrane| |cellular ketone metabolic process| |regulation of mitochondrial membrane permeability| |regulation of establishment of protein localization to mitochondrion| |regulation of membrane permeability| |protein lipidation| |lipoprotein biosynthetic process| |positive regulation of mitochondrion organization| |lipoprotein metabolic process| |positive regulation of protein localization to membrane| |mitochondrial membrane organization| |regulation of G protein-coupled receptor signaling pathway| |positive regulation of apoptotic signaling pathway| |regulation of mitochondrion organization| |protein acylation| |regulation of protein localization to membrane| |mitochondrial transport| |positive regulation of cellular protein localization| |in utero embryonic development| |regulation of apoptotic signaling pathway| |mitochondrion organization| |positive regulation of establishment of protein localization| |regulation of cellular protein localization| |positive regulation of organelle organization| |chordate embryonic development| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |embryo development ending in birth or egg hatching| |positive regulation of cell death| |regulation of establishment of protein localization| |membrane organization| |peptidyl-amino acid modification| |regulation of cellular localization| |embryo development| |positive regulation of transport| |regulation of protein localization| |regulation of response to external stimulus| |positive regulation of cellular component organization| |mitochondrion| |regulation of organelle organization| |organonitrogen compound biosynthetic process| |regulation of apoptotic process| |regulation of programmed cell death| |positive regulation of signal transduction| |regulation of cell death| |cellular macromolecule biosynthetic process| |small molecule metabolic process| |macromolecule biosynthetic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.68| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|-2.44| |[[:results:exp134|MS023 2μM R03 exp134]]|-2.32| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.26| |[[:results:exp33|Rotenone 2μM R00 exp33]]|-2.08| |[[:results:exp469|CFI-400945 25μM R08 exp469]]|-2.06| |[[:results:exp143|Phenformin 20μM R03 exp143]]|-2.06| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.99| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.98| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-1.95| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-1.76| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|-1.71| |[[:results:exp463|Caffeine 2600μM R08 exp463]]|-1.7| |[[:results:exp436|Dynasore 7μM R08 exp436]]|1.88| |[[:results:exp182|IU1-47 25μM R04 exp182]]|2.21| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 353/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|14/28| |blood|15/28| |bone|11/26| |breast|16/33| |central nervous system|22/56| |cervix|2/4| |colorectal|12/17| |esophagus|9/13| |fibroblast|0/1| |gastric|11/16| |kidney|2/21| |liver|11/20| |lung|33/75| |lymphocyte|11/16| |ovary|10/26| |pancreas|12/24| |peripheral nervous system|6/16| |plasma cell|11/15| |prostate|0/1| |skin|10/24| |soft tissue|4/9| |thyroid|0/2| |upper aerodigestive|17/22| |urinary tract|19/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1976 * **Expression level (log2 read counts)**: 7.04 {{:chemogenomics:nalm6 dist.png?nolink |}}